A novel clinical sign in macular telangiectasia type 2

Animesh Jindal, Himadri Choudhury, Avinash Pathengay, Harry W. Flynn

Research output: Contribution to journalReview article

3 Scopus citations

Abstract

The objective of the study is to report, and propose a hypothesis for, a novel clinical sign in patients with macular telangiectasia type 2. Nine consecutive patients with macular telangiectasia and visible parafoveal graying were examined. The parafoveal graying decreased in intensity with continuous light exposure from an indirect ophthalmoscope. After dark adaptation for 15 minutes, the intensity of parafoveal graying increased again. This phenomenon appears to be a novel and global sign in patients with macular telangiectasia type 2. It could be a possible photochemical reaction occurring due to the release of chromophores from the abnormal Müller cells.

Original languageEnglish (US)
Pages (from-to)134-136
Number of pages3
JournalOphthalmic Surgery Lasers and Imaging Retina
Volume46
Issue number1
DOIs
StatePublished - Jan 1 2015

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology

Fingerprint Dive into the research topics of 'A novel clinical sign in macular telangiectasia type 2'. Together they form a unique fingerprint.

  • Cite this